Results 41 to 50 of about 170,342 (313)

T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients

open access: yesPLOS ONE, 2022
The cognitive impairment, depression, a decrease in the ability to perform activities of daily living (ADLs), and salivary gland dysfunction, as indicated by the reduction of alpha-amylase activity, have been reported in patients with type 2 diabetes (T2DM).
Savitree Thummasorn   +8 more
openaire   +3 more sources

ROC curve analysis for SOST and irisin in T2DM+ATHR and T2DM-ATHR groups.

open access: yes, 2018
ROC curve analysis for SOST and irisin in T2DM+ATHR and T2DM-ATHR groups.
Ibrahim Ali Emara (5942729)   +4 more
core   +1 more source

Microvascular Damage Is Associated With Carotid Wall Structural Changes in Systemic Sclerosis: A Capillaroscopy and Ultrasound‐Based Observational Study

open access: yesArthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is characterized by cardiovascular risk excess not fully explained by traditional factors. Whether the severity of microvascular damage correlates with structural subclinical atherosclerosis remains unclear. We investigated the relationship between nailfold videocapillaroscopy (NVC) abnormalities and carotid ...
Eugenio Capparelli   +13 more
wiley   +1 more source

Molecular Pathways Regulating Circadian Rhythm and Associated Diseases

open access: yesFrontiers in Bioscience-Landmark
Circadian rhythms, the natural cycles of physical, mental, and behavioral changes that follow a roughly 24-hour cycle, are known to have a profound effect on the human body.
Min Ding   +3 more
doaj   +1 more source

Multinomial logistic regression for odds ratios of T2DM, NAFLD and NAFLD+T2DM according to Circulating CTRP13.

open access: yes, 2016
Multinomial logistic regression for odds ratios of T2DM, NAFLD and NAFLD+T2DM according to Circulating CTRP13.
Nariman Moradi (3391952)   +4 more
core   +1 more source

Changes in liver steatosis and liver stiffness following Empagliflozin treatment in patients with MASLD and type 2 diabetes: A single-arm pre-post study. [PDF]

open access: yesJ Diabetes Investig
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is common in subjects with type 2 diabetes mellitus (T2DM), being linked to a higher risk for the development of liver‐related and cardiovascular diseases.
Shieh M   +3 more
europepmc   +2 more sources

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

open access: yesAdvanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang   +9 more
wiley   +1 more source

Cummulative incidence of lung cancer compared among COPD patients with T2DM, without T2DM and comparison subjects.

open access: yes, 2014
Cummulative incidence of lung cancer compared among COPD patients with T2DM, without T2DM and comparison subjects.
Wu-Huei Hsu (199307)   +10 more
core   +1 more source

OAF Blocks SIAH1‐Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD

open access: yesAdvanced Science, EarlyView.
This study shows OAF directly binds to SCPX and inhibits its interaction with the E3 ligase SIAH1, thereby protecting SCPX from ubiquitin‐dependent degradation and stabilizing its levels. This OAF‐SCPX axis represents a novel pathway in lipid homeostasis, highlighting OAF as a promising therapeutic candidate for MASLD.
Zongxi Li   +11 more
wiley   +1 more source

Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis

open access: yesФармакоэкономика, 2017
To date, several options for starting and intensifying insulin therapy in patients with type 2 diabetes mellitus (T2DM) have been proposed. Meta-analyzes of the recent results shows that, with adequate use, all these regimens have the similar efficacy ...
E. V. Biryukova, V. I. Ignat’eva
doaj   +1 more source

Home - About - Disclaimer - Privacy